Importance of lifestyle counselling by primary care physicians for diabetic patients

Swiss Medical Weekly

Volumn 136, Issue 35-36, 2006, Pages 566-573

  Sebo, Paul ^a   Abetel, Gilbert ^b   Stalder, Hans ^a   Bovier, Patrick A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

Counselling; Diabetes; Primary care; Quality of care

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COUNSELING; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; HUMAN; INFLUENZA VACCINATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PATIENT CARE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PHYSICIAN; PRIMARY MEDICAL CARE; PROFESSIONAL PRACTICE; RETINOPATHY;

EID: 33749460007     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005;28:2130-5.
2. Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2005.
3. Lyratzopoulos G, McElduff P, Heller RF, Hanily M, Lewis PS. Comparative levels and time trends in blood pressure, total cholesterol, Body Mass Index and smoking among Caucasian and South-Asian participants of a UK primary-care based cardiovascular risk factor screening programme. BMC Public Health 2005;5:125.
4. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-209.
5. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ 1998;317:713-20.
6. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13.
7. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
8. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999;353:617-22.
9. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65.
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
11. Connor H, Annan F, Bunn E, Frost G, McGough N, Sarwar T, et al. The implementation of nutritional advice for people with diabetes. Diabet Med 2003;20:786-807.
12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
13. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose-tolerance. N Engl J Med 2001;344:1343-50.
14. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-9.
15. Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005;21:1477-83.
16. Killilea T. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care. Am J Manag Care 2002;8:S441-9.
17. Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, et al. Predictors of health care costs in adults with diabetes. Diabetes Care 2005;28:59-64.
18. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003;26:2300-4.
19. Schmitt-Koopmann I, Schwenkglenks M, Spinas GA, Szucs TD. Direct medical costs of type 2 diabetes and its complications in Switzerland. Eur J Public Health 2004;14:3-9.
20. Morabia A, Costanza MC. The obesity epidemic as harbinger of a metabolic disorder epidemic: trends in overweight, hypercholesterolemia, and diabetes treatment in Geneva, Switzerland, 1993-2003. Am J Public Health 2005;95:632-5.
21. Eichholzer M, Camenzind E. Surcharge pondérale, obésité et poids insuffisant en Suisse: résultats de l'étude Nutri-Trend 2000. Bull. OFSP 2003;20:339-40.
22. Luong BL, Beer-Borst S, Morabia A. Surcharge pondérale, obésité et poids insuffisant à Genève: résultats de l'étude du Bus Santé, 1993-2001. Bull. OFSP 2003;38:659.
23. Freeman A, Hall M. Diabetes mellitus. In: Marshall M, Campbell S, Hacker J, Roland M. Quality indicators for general practice. Glasgow, Royal Society of Medicine Press Ltd., 2002: 38-45.
24. Kuntschen F, Rohrer-Theus A. La prise en charge moderne du diabète de type 2. Bulletin des médecins suisses 2000;81:1405-6.
25. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S33-50.
26. Goudswaard AN, Stolk RP, Zuithoff P, Rutten GE. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care. Eur J Epidemiol 2004;19:541-5.
27. Pringle M, Stewart-Evans C, Coupland C, Williams I, Allison S, Sterland J. Influences on control in diabetes mellitus: patient, doctor, practice, or delivery of care? BMJ 1993;306:630-4.
28. Blaum CS, Velez L, Hiss RG, Halter JB. Characteristics related to poor glycemic control in NIDDM patients in community practice. Diabetes Care 1997;20:7-11.
29. Assuncao MC, Santos IS, Valle NC. Blood glucose control in diabetes patients seen in primary health care centers. Rev Saude Publica 2005;39:183-90.
30. Goldfracht M, Porath A. Nationwide program for improving the care of diabetic patients in Israeli primary care centers. Diabetes Care 2000;23:495-9.
31. Saadine JB, Cadwell B, Gregg EW, Engelbau MM, Vinicor F, Imperatore G, et al. Improvement in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 2006;144:465-74.
32. Acton KJ, Shields R, Rith-Najarian S, Tolbert B, Kelly J, Moore K, et al. Applying the diabetes quality improvement project indicators in the Indian Health Service primary care setting. Diabetes Care 2001;24:22-6.
33. Valle T, Koivisto VA, Reunanen A, Kangas T, Rissanen A. Glycemic control in patients with diabetes in Finland. Diabetes Care 1999;22:575-9.
34. Harris SB, Ekoe JM, Zdanowicz Y, Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract 2004;70:90-7.
35. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-9.
36. Hansen LJ, Olivarius Nde F, Siersma V, Andersen JS. Doctors' characteristics do not predict long-term glycaemic control in type 2 diabetic patients. Br J Gen Pract 2003;53:47-9.
37. Ceriello A, Motz E. Is oxydative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardio-vascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-23.
38. Okoro CA, Mokdad AH, Ford ES, Bowman BA, Vinicor F, Giles WH. Are persons with diabetes practicing healthier behaviors in the year 2001? Results from the Behavioral Risk Factor Surveillance System. Prev Med 2004;38:203-8.